Aventusoft, LLC

Aventusoft, LLC is a Boca Raton, Florida-based medical technology company specializing in signal detection analysis and AI-driven digital health platforms since 2010. The company develops innovative solutions focused on cardiac monitoring, clinical decision support, and decentralized clinical research. Primary product lines include Hemotag, a non-invasive cardiac monitoring device paired with AI analytics to reduce reliance on invasive cardiac imaging and implantable devices; CarePear, a digital health platform connecting patients and physicians with US-based sub-specialists through AI-enabled telemedicine; and Trialogy, an AI-driven platform for decentralized clinical trials that streamlines life science research. Aventusoft has received recognition from the NIH (RADx Tech for Maternal Health Challenge), DARPA, American College of Cardiology (ACC Innovation Showcase Award 2021 and 2023), and multiple design and innovation awards. The company demonstrated 146% two-year revenue growth and ranked No. 112 on Inc. Magazine's 2023 Southeast Region fastest-growing private companies list. Products target cardiac care, maternal health, specialist access, and clinical research domains, with regulatory focus on maternal health applications and AI-driven diagnostics.